United Therapeutics Corporation (NASDAQ: UTHR) CEO Martine A. Rothblatt, on Wednesday, bought 13,649 shares of the company for $43.60 per share.
Rothblatt has purchased UTHR shares on 7 other occasions in the past year. The average price for these purchases has been $42.15 per share.
[...]
Recent Comments